<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(1)</volume><submitter>Brown RF</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Shared Decision Making (SDM) is widely accepted as the preferred method for reaching treatment decisions in the oncology setting including those about clinical trial participation: however, there is some disagreement between researchers over the components of SDM. Specific standardized coding systems are needed to help overcome this difficulty.&lt;h4>Objective&lt;/h4>The first objective was to describe the development of an oncology specific SDM coding system, the DAS-O. The second objective was to provide reliability and validity data supporting the DAS-O.&lt;h4>Setting and participants&lt;/h4>Consultation data were available from tertiary cancer center out patient oncology clinics in: Australia, New Zealand (ANZ), Switzerland, Germany and Austria (SGA). Patients were women with a confirmed diagnosis of early stage breast cancer. Reliability data were from 18 randomly selected coded transcripts drawn from ANZ and SGA. Concurrent validity data are from 55 (ANZ) consultations.&lt;h4>Measurement&lt;/h4>Inter and Intra rater reliability data was evaluated using Kappa correlation statistics and correlation coefficients. Correlation coefficients were used to assess concurrent validity between the DAS-O and two other SDM coding systems, OPTION and DSAT.&lt;h4>Results&lt;/h4>Inter and Intra rater reliability for the system were high with average Kappas of 0.58 and 0.65 respectively. Correlation coefficients between DAS-O and OPTION was 0.73 and >0.5 for DSAT.&lt;h4>Conclusions&lt;/h4>We have developed a reliable and valid coding system for identifying and rating the quality of SDM in breast cancer consultations.</pubmed_abstract><journal>Health expectations : an international journal of public participation in health care and health policy</journal><pagination>29-37</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5060562</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Sharing decisions in breast cancer care: Development of the Decision Analysis System for Oncology (DAS-O) to identify shared decision making during treatment consultations.</pubmed_title><pmcid>PMC5060562</pmcid><pubmed_authors>Tattersall MH</pubmed_authors><pubmed_authors>Bernhard J</pubmed_authors><pubmed_authors>Brown RF</pubmed_authors><pubmed_authors>Ribi K</pubmed_authors><pubmed_authors>Gerber D</pubmed_authors><pubmed_authors>Butow PN</pubmed_authors><pubmed_authors>Juraskova I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Sharing decisions in breast cancer care: Development of the Decision Analysis System for Oncology (DAS-O) to identify shared decision making during treatment consultations.</name><description>&lt;h4>Background&lt;/h4>Shared Decision Making (SDM) is widely accepted as the preferred method for reaching treatment decisions in the oncology setting including those about clinical trial participation: however, there is some disagreement between researchers over the components of SDM. Specific standardized coding systems are needed to help overcome this difficulty.&lt;h4>Objective&lt;/h4>The first objective was to describe the development of an oncology specific SDM coding system, the DAS-O. The second objective was to provide reliability and validity data supporting the DAS-O.&lt;h4>Setting and participants&lt;/h4>Consultation data were available from tertiary cancer center out patient oncology clinics in: Australia, New Zealand (ANZ), Switzerland, Germany and Austria (SGA). Patients were women with a confirmed diagnosis of early stage breast cancer. Reliability data were from 18 randomly selected coded transcripts drawn from ANZ and SGA. Concurrent validity data are from 55 (ANZ) consultations.&lt;h4>Measurement&lt;/h4>Inter and Intra rater reliability data was evaluated using Kappa correlation statistics and correlation coefficients. Correlation coefficients were used to assess concurrent validity between the DAS-O and two other SDM coding systems, OPTION and DSAT.&lt;h4>Results&lt;/h4>Inter and Intra rater reliability for the system were high with average Kappas of 0.58 and 0.65 respectively. Correlation coefficients between DAS-O and OPTION was 0.73 and >0.5 for DSAT.&lt;h4>Conclusions&lt;/h4>We have developed a reliable and valid coding system for identifying and rating the quality of SDM in breast cancer consultations.</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Mar</publication><modification>2021-02-21T12:06:01Z</modification><creation>2019-03-27T02:26:28Z</creation></dates><accession>S-EPMC5060562</accession><cross_references><pubmed>20629766</pubmed><doi>10.1111/j.1369-7625.2010.00613.x</doi></cross_references></HashMap>